Improved Serum Phosphorus (SP) Control With Fewer Pills/Day Among African-American Hemodialysis (HD) Patients Prescribed Sucroferric Oxyhydroxide (SO) for Two Years

Publication date: March 2019Source: Advances in Chronic Kidney Disease, Volume 26, Issue 2Author(s):
Source: Advances in Chronic Kidney Disease - Category: Urology & Nephrology Source Type: research